Advanced Search
Contact | Corporate | Help

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Sponsors:
  • Johns Hopkins University
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • Genentech
Phases:
  • Phase III
IndicationsAcronym:
CLEAR III
  • Intraventricular Hemorrhage
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Cathflo Activase
  • Other: Normal saline
Enrollment:
500

Additional information about NCT00784134.


SourceSolution © 2008-2012